The newly cleared capability uses AI through the smartSET pulse oximetry sensor platform.

The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from ...

On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...

Danaher operates across biotechnology, diagnostics, and life sciences markets. Explore recent FDA developments, healthcare ...

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 2.8% in the morning session after its recently ...

Danaher Corporation DHR has completed the acquisition of Masimo Corp. for $180 per share in cash. The transaction was valued ...

Details How Independent Third Parties and the Evidence in Legal Proceedings Have Consistently Refuted Masimo’s “Defensive Rhetoric” and How Company’s Attacks on Politan Continue to “Crumble Under ...

View Masimo Corporation MASI stock quote prices, financial information, real-time forecasts, and company news from CNN.

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of ...

Masimo activist Quentin Koffey says he'll pursue litigation if the health-tech company doesn't provide information on a proposed spinout of a business unit. Koffey said the company demanded directors ...

Medical device company Masimo took the unusual step of subpoenaing Glass Lewis and ISS for their private communications with shareholders about Masimo's upcoming proxy fight with activist investor ...

Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...